Abstract
Glutaric aciduria type I is an autosomal recessive disorder resulting from glutaryl-CoA de- hydrogenase(GCDH) deficiency. Untreated patients commonly present with severe striatal degeneration and ex- trapyramidal sequelae during encephalopathic crises. GCDH deficiency leads to accumulation of glutaric acid and 3-hydroxyglutaric acid in tissues and body fluids (especially in brain), which are neurotoxic. There is no correla- tion between residual enzyme activity caused by mutations in GCDH and phenotype. The pathogenesis of glutaric aciduria type I is complicated. Previous studies have demonstrated that glutaric and 3-hydroxyglutaric acids are synthesized in central nervous system and trapped because of limiting transport across the blood-brain barrier. The studies on metabolite-mediated neurotoxicity mainly focus on excitotoxicity,impairment of energy metabo- lism and oxidative stress. In addition, activation of astrocyte, vascular derangements,inflammatory processes may be a synergism of neurotoxicity. Key words: Glutaric aciduria; Neurotoxicity; Excitotoxicity; Impairment of energy metabolism; Oxida- tive stress
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.